Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence

Kinnari Pandya(Loyola University Chicago), Clodia Osipo(Loyola University Chicago)
British Journal of Cancer
August 16, 2011
Cited by 131


Related Papers